Antibiotic-free remedy aims to conquer bacterial vaginosis
Ferring, Rebiotix and MyBiotics collaborate to develop live microbiome-based biotherapeutics in reproductive medicine and maternal health.
Illustrative photo by Imani Bahati on Unsplash
A live biotherapeutic remedy based on a woman’s female microbiome is under development to treat bacterial vaginosis. This common infection among women of reproductive age is linked to increased risk of miscarriage and complications to pregnancy and fertility.
The treatment is being developed in a partnership among Ferring Pharmaceuticals of Switzerland, Ferring subsidiary Rebiotix of Minnesota, and MyBiotics Pharma of Rehovot, Israel.
Currently, bacterial vaginosis is treated with antibiotics, which can disrupt the vaginal microbiome and does not prevent the infection from reoccurring. The aim of a microbiota-based treatment would be to reduce antibiotic use and provide a long-term treatment solution.
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility.1,2,3 The collaboration is an important step forward in harnessing the power of the human microbiome in this area of women’s health.
Currently bacterial vaginosis is treated with antibiotics, which can disrupt the vaginal microbiome, and it’s common for bacterial vaginosis to return following treatment.4 The aim of a microbiota-based treatment would be to reduce the need for antibiotic use and provide a long-term treatment solution.
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.